LMO2 Peptide - N-terminal region (AAP31307)

LMO2 Peptide - N-terminal region (AAP31307)
Artikelnummer
AVIAAP31307-100UG
Verpackungseinheit
100µg
Hersteller
Aviva Systems Biology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Description of Target: This is a synthetic peptide designed for use in combination with anti-LMO2 antibody (Catalog #: P100952_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

Key Reference: Yuan,W., (2008) Leukemia 22 (5), 1067-1071

Molecular Weight: 18kDa

Product Format: Lyophilized powder

Protein Size: 158
Mehr Informationen
Artikelnummer AVIAAP31307-100UG
Hersteller Aviva Systems Biology
Hersteller Artikelnummer AAP31307-100UG
Green Labware Nein
Verpackungseinheit 100µg
Mengeneinheit STK
Methode Western Blotting
Human Gene ID 4005
Produktinformation (PDF)
×
MSDS (PDF)
×